News and research before you hear about it on CNBC and others. Claim your one week free trial for StreetInsider Premium here.

StatLab Expands Global Reach and Core Manufacturing Capabilities with Acquisition of CellPath Ltd.

MCKINNEY, Texas–(BUSINESS WIRE)–StatLab Medical Products (StatLab), a portfolio company of Audax Private Equity and Linden Capital Partners and a leading developer and manufacturer of medical diagnostic supplies and equipment , today announced the acquisition of CellPath Ltd. (CellPath), a UK manufacturer and supplier of products and services focused on the histology and cytology markets. This addition of new manufacturing capabilities and an established customer base in the UK both strengthens the core business and positions StatLab for international growth and market expansion.

This press release is multimedia. View the full press release here: https://www.businesswire.com/news/home/20220607006320/en/

Based in the UK, CellPath was founded in 1969 by Peter Webber as a histology consumables company known as Bethlehem Instruments, and quickly expanded into equipment. Today, CellPath is an established market leader in Europe, providing key products and services to the cytology and histology market segments. With this acquisition, StatLab expands its reach in Europe, adds key injection molding manufacturing capabilities, and acquires proprietary products, including the CellNass archiving service.

“We have long respected CellPath for its well-earned reputation for providing innovative products that solve lab problems, and we are proud to welcome them to the StatLab family of brands,” said Mike Karsonovich, CEO of StatLab. the acquisition of UK-based equipment manufacturer Pyramid Innovation in 2021, CellPath’s established position in the European market and its complementary portfolio will enable significant international growth in the histology sector.

Philip Webber, co-CEO of CellPath with his brother Paul, adds, “StatLab is a perfect fit for us; their access to the US market and business infrastructure will jointly help expand customer access to products and services as a global market leader. We also appreciate their leadership commitment to ensure that we maintain the high levels of service and quality for which the family business is known, as we combine into one organization.

CellPath will continue to operate in the same locations and under the existing management structure to avoid any business disruption.

About StatLab Medical Products

Founded in 1976, StatLab Medical Products is at the forefront of developing and manufacturing high quality histology, cytology and immunohistochemistry diagnostic products. We partner with pathology laboratories to provide easy access to over 3,500 high-quality diagnostic products and equipment at excellent prices, delivered with expert support. When you work with StatLab, we are part of your team and you are part of our family. Learn more at StatLab.com.

About CellPath Ltd.

CellPath Limited is a UK based company specializing in the manufacture and global supply of products, consumables and services to the Cell Pathology industry. The CellPath name is synonymous with innovative and proven products, manufactured to very high standards. With state-of-the-art in-house injection molding capability, they manufacture many of the plastic products used in the modern histology and cytology laboratory, and their ability to sell directly from manufacture to the end user helps reduce costs without compromise on quality and services.

See the source version on businesswire.com: https://www.businesswire.com/news/home/20220607006320/en/

Jessica Baer

[email protected]

Source: StatLab Medical Products